To further determine the biological function of DLX5, we divided CRC patient samples from the TCGA dataset into high and low expression groups according to the DLX5 expression levels and used gene set enrichment analysis (GSEA) to assess the characteristic signaling pathways in patients with high DLX5 expression. The gene discussed is DLX5; the disease is colorectal carcinoma.